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Abstract
Background: A training physician has his first interaction with a pharmaceutical representative during medical
school. Medical students are often provided with small gifts such as pens, calendars and books, as well as free lunches
as part of drug promotion offers. Ethical impact of these transactions as perceived by young medical students has not
been investigated in Pakistan before. This study aimed to assess the association of socio-demographic variables with
the attitudes of medical students towards pharmaceutical companies and their incentives.
Methods: As part of a cross-sectional survey, a validated questionnaire previously used for assessing attitude of medical
students towards pharmaceutical industry, was modified, pre-tested and distributed among consenting clinical year
students at DUHS and AKU. Questions included acceptability of pharmaceutically sponsored gifts, events and tuition
fee, and their impact on future prescription. Responses were graded as agree, disagree or neutral which were then
scored according to the AMSA guidelines of ethical conduct.
Results: Out of a total of 353 targeted students 303 responded, corresponding to a response rate of 85.8%. Responses
indicated that 42.7% students believed in no interaction with drug companies during medical school. However,
81% of students favored pharmaceutical sponsorship of student-body events/seminars at medical colleges. More
than one-third of the students were comfortable receiving gifts from drug companies. Overall, the results of this
study offer an interesting comparison between the students of a private medical school (AKU) and a public
medical school (DUHS); AKU students exhibited a greater degree of mistrust towards drug information provided
by pharmaceutical companies compared to DUHS students (p = 0.040). Furthermore, when asked if there was a
need to incorporate guidelines in the undergraduate curriculum with regard to interaction with drug companies,
84.2% students at AKU agreed, compared to 54.9% at DUHS. Medical student Attitude Scores are more or less
similar to each other independent of their various demographical differences.
Conclusion: This study highlights that medical students in our population have a high level of acceptability
towards incentives offered by pharmaceutical industry and that formal guidance regarding the subject should be
incorporated into medical curriculum.
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Background
The importance of the relationship of a practicing phys-
ician with pharmaceutical industry and its representatives
is irrefutable. According to previous estimates, 85-90% of
medical doctors in US, Canada, Britain and New Zealand
meet with pharmaceutical representatives (PR) [1]. PRs
are drug marketing personals who approach physicians,
present research and provide incentives, all of which is
aimed towards convincing the physician to prescribe
their brand. Incentives include drug promotional offers
and also free samples, gifts and sponsorship of confer-
ences among others. At this point, three key factors
need to be considered: the appropriateness of accepting
these incentives, favoring a particular company based on
such incentives, and being able to objectively scrutinize
the worth of the drug as well as that of the research being
presented to support it.
The concern for drug company-physician relationship
and its negative influence on prescription writing, has
led numerous professional organizations, such as the
American Medical Association (AMA) and the American
Medical Student Association (AMSA), to develop guide-
lines and recommendations. AMSA recommendations
discourage physicians and students from accepting gifts
from drug companies, urge hospitals and residency pro-
grams to discontinue drug company-funded lectures and
lunches, and oppose continuing medical education (CME)
granted credit for drug company-sponsored events [2].
In this regard, AMSA initiated its PharmFree campaign
in 2002 and released a policy statement regarding best
practice aimed for the benefit of both practicing and train-
ing physicians. This policy aims to guide medical doctors
and students towards ethically sound attitudes that should
be fostered towards pharmaceutical industry sponsored
gifts and meals, free pharmaceutical samples, pharma-
ceutical representatives, conferences and “indulgence”
of pharma industry in medical student education and train-
ing. An excerpt from the current AMSA pharma-free pol-
icy is as below:
1. Gifts and Meals: Best Practice: All gifts and on-site
meals funded by industry are prohibited, regardless
of nature or value.
2. Pharmaceutical Samples: Best Practice: Industry
samples are prohibited, except under certain narrow
circumstances approved by the institution that
protect the interests of indigent patients and prevent
the use of samples as a marketing tool.
3. Drug Representatives: Best Practice: Pharmaceutical
and device representatives are not allowed to market
their products anywhere inside the medical center
and associated clinics and offices.
4. On-site Educational Activities: Best Practice:
Industry is not permitted to provide direct financial
support for educational activities, including CME,
directly or through a subsidiary agency.
5. Compensation for Travel or Attendance at Off-site
Lectures & Meetings: Best Practice: Personnel may
not accept payment, gifts or financial support from
industry to attend lectures and meetings.
6. Industry Support for Scholarships & Funds for
Trainees: Best Practice: The policy must either
prevent industry from earmarking or awarding funds
to support the training of particular individuals.
7. Medical school curriculum (or other documentation
of educational objectives/course content): Best
Practice: Students are to be trained to understand
institutional conflict-of-interest policies and
recognize how industry promotion can influence
clinical judgment.
One must realize that the very first interaction that a
physician-in-training has with a pharmaceutical repre-
sentative is during the early years of medical school
[3-5]. In many instances, medical students are provided
with small gifts as pens, calendars and books, as well as
free lunches as part of drug promotion offers [6]. Studies
at various US and Canadian medical schools have found
that students receive many such gifts and their interaction
with PRs is quite common; some studies have shown this
interaction to be as frequent as ten times per month
[3,7-11]. Additional studies have suggested that medical
students tend to favor these interactions (3–7). Compar-
able results were demonstrated in a recent study from
India [11]. This has led many critics to believe that these
subliminal marketing strategies affect prescription-writing
behavior when these students enter the professional world
(8, 11). However, literature assessing medical students’
attitudes and exposures to the pharmaceutical industry
and the marketing tactics deployed by them is quite
sparse. Available studies report that most students believe
that they are not much affected by the marketing schemes
used by the pharmaceutical companies [12,13]. Many
regard receiving trivial gifts from the pharmaceutical com-
panies as ethically correct. For instance, one study found
that although 85% of medical students believed it to be
highly improper for a politician to receive a $50 gift, how-
ever receiving a similar gift from a pharmaceutical repre-
sentative themselves was regarded as unsuitable by only
46% of students (10). Nevertheless, many have sensed the
serious lack of training at undergraduate level pertaining
to student interactions with PRs [10]. Substantial deficits
have been found in students’ knowledge about pharma-
ceutical marketing expenditures, professional ethics and
accuracy of drug information from pharmaceutical repre-
sentatives [5,10].
Strong evidence suggests that medical students are
at-risk of being influenced by pharmaceutical company
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marketing strategies in the form of free gifts [5,14,15].
Students who receive gifts may believe that they are
receiving something for nothing, contributing to a sense
of entitlement which is not in the best interests of their
moral development as future doctors. Alternatively, stu-
dents may be subject to recognized or unrecognized
reciprocal obligations that potentially influence their
decision making [16]. A randomized controlled experi-
ment by Grand D et al. validated that subtle exposure to
even small pharmaceutical promotional items influ-
ences implicit attitudes towards marketed products
among medical students [10].
According to the Pakistan Medical and Dental Council
(PMDC), the number of medical schools in Pakistan has
considerably increased in the past 15 years from a mere
30 in the year 2000 to almost 90 in 2013. Out of these,
38 are public and 52 are private institutions. The struc-
ture of medical education in Pakistan varies considerably
in terms of teaching methods. However, all programs
consist of a 5-year rigorous training curriculum during
medical school. This is usually followed by relevant spe-
cialty training/residency. Medical college falls under a
specific university in its undergraduate medical education
(UGME) program. Each university also usually has its own
residency programs for multiple specialties under its post-
graduate medical education (PGME) program.
A literature search was conducted on Pubmed/Med-
line using the keywords “attitudes”, “medical students”,
“pharmaceutical industry”, “Education, Medical, Under-
graduate” and “Pakistan” in different combinations to
identify studies from Pakistan. To the best of our know-
ledge, we found no similar studies on the presented
topic. This in itself enhances the need for conducting
such a study in Pakistan. We, as medical students, have
observed that PRs approach students in pharmaceutical
exhibitions held within college premises, at medical con-
ferences and also during outpatient clinics. Often at
times, there is an exchange of small gift items and free
meals. Ethical impact of these transactions as perceived
by young medical students has not been investigated in
Pakistan before.
Through this study, we aim to assess the attitude of
medical students towards: a) gifts and sponsorship offered
by pharmaceutical companies, b) effects of pharmaceutical
marketing on prescribing behavior of physicians, c) inter-
action between pharmaceutical companies and healthcare
professionals. We also aim to investigate the differences
of opinions between medical students from public-
sectored and private institutes. Finally, we aim to assess
the association between socio-demographic variables and
the subsequent attitude of medical students towards
pharmaceutical companies and their incentives. To the
best of our knowledge, this study is the first attempt
by any authority to gauge not only the attitudes and
perceptions of medical students regarding the phar-
maceutical industry, but also to identify the socio-
demographic patterns related to such thinking.
Methods
This is a cross-sectional study carried out at two med-
ical colleges in Karachi, Pakistan. Aga Khan University
(AKU) Medical College was chosen to represent the
largest private medical set-up in the country with an
average batch of 100 students and Dow University of
Health Sciences (DUHS) representing a leading public
sector medical institution with an average class size of
200 students. Karachi is the largest cosmopolitan city
of Pakistan. This was a favorable factor given the city’s
diverse population belonging to different social strata.
Convenience sampling was employed. Sample size was
calculated assuming the proportion of favorable attitudes
towards pharmaceuticals to be 50%. A confidence interval
of 95% and bound on error of 5% were utilized. Open
Epi was used to calculate the sample size which was 282.
Assuming a predicted response rate of 80%, the adjusted
sample size came out to be 353 individuals.
All male and female medical students, currently in
their clinical years (which correspond to the third, fourth
and fifth year of the Bachelor of Medicine & Bachelor of
Surgery [MBBS] program), formally enrolled at AKU or
DUHS medical college were included. All students in-
volved in the study design or conduction in any capacity,
and those students on whom the questionnaire was pre-
tested were excluded from the study.
The definition of attitude was taken as suggested in
the oxford dictionary; ‘a settled way of thinking or feeling
reflected in a person’s behavior’. In sociology attitude is
taken to be an orientation (towards a person, situation,
institution, or social process) which is indicative of an
underlying value or belief.
In order to assess the ‘attitude’ of medical students to-
wards the pharmaceutical industry in our setting, a vali-
dated questionnaire suited for medical students was
adapted from a similar study by Joseph Barfett et al. [17]
(Attached as Additional file 1). With the help of this
questionnaire, we evaluated the willingness of medical
students to have any form of interaction with pharmaceut-
ical representatives and their perceived appropriateness of
accepting various ‘gifts and favors’ from pharmaceutical
industry.
Modifications in the questionnaire made for this study
included the conversion of Dollars ($) to Pakistani Rupee
(Rs.) in the question regarding parental income. Two sup-
plementary open-ended questions were included which
enquired about the form of individual interaction with
pharmaceutical industry and its influence on the students.
These additions were deemed necessary because the issue
at hand is relatively under-investigated in our setting and
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the exact manner of student interaction with pharmaceut-
ical representatives and its impact has not been well-
characterized. The modified version of this questionnaire
was pre-tested before being administered to actual partici-
pants. This was done by directing the questionnaire to a
select group comprising of fifty medical students from
Aga Khan Medical College, who were not involved in the
actual study later. During pre-testing, difficulty with ques-
tions, instructions, order of questions or responses was
considered, and the time taken to fully answer the ques-
tionnaire was duly recorded. Questions were assessed to
be unambiguous and socially apt; no problems were iden-
tified and hence, no further modifications were required.
The questionnaire comprised of nineteen questions
and was divided into two parts. In order to maintain
participant confidentiality, no personal information was
sought. The first part dealt with five questions pertaining
to the study populations’ demographic and socioeco-
nomic details. Students were asked to give information
regarding their sex, year of study, average monthly par-
ental income, and parent’s profession as a physician or
belonged to the pharmaceutical industry. The second
part of the questionnaire consisted of fourteen questions
evaluating the medical students’ views towards inter-
action with pharmaceutical representatives and the in-
centives they offered. This was done with the help of
hypothetical scenarios and relevant inquiry about their
potential attitudes in such situations. These questions
were grouped into three categories for analysis of re-
sponses; attitude regarding receiving gifts from pharma-
ceutical representatives, event and tuition fee sponsorship
by pharmaceutical industry and the subsequent impact of
these incentives on prescription preferences later during
practice. Nine of the fourteen questions consisted of
pre-defined responses of ‘Agree’, ‘Neutral’, and ‘Disagree’.
Multiple choice answers were offered to three questions.
The final part of the questionnaire consisted of two open
ended questions where students were asked about their
views relating to student-industry interactions and to
specify if any particular experience relating to such in-
teractions had influenced their responses to the entire
questionnaire. As no legal rules and regulations exist in
our medical setting regarding interactions between the
pharmaceutical industry and medical students, AMSA
guidelines were followed in order to define inappropri-
ate and appropriate attitude.
A cumulative score was calculated as an overall por-
trayal of medical student’s attitudes; this new attitude
scoring (ATT Score) system was developed depending
on the respondents’ answers to the individual questions in
the questionnaire and has not been used before. Students
demonstrating a compliant attitude towards pharma-
ceutical companies were given a higher score and those
displaying reservations towards the same were given
lower scores. Answers revealing favorable attitudes
towards medical student-PR interactions were given a
score of 3, all neutral responses were given a score of 2 and
student responses showing strict attitudes towards drug
companies were given a score of 1. Cumulative scores for
each respondent were then calculated (ATT Score)
The study protocol was approved by the Ethics Review
Committee of the Aga Khan University Hospital. The
consent form was approved in both English and Urdu
languages. In order to ensure preservation of meaning,
Urdu consent form was translated back into English.
Individual permission to conduct survey was sought
from the respective deans of AKU and DUHS medical
colleges. Both male and female students belonging to
clinical years were approached in the medical college
courtyard at both institutions, during break hours.
Background, purpose and significance of the study were
explained to the participants, and consent was sought
before enrollment. All consenting participants were
requested to fill out the questionnaires. They were given
ample time to respond in privacy to ensure confidentiality
and freedom of response without fear of judgment. No
attempt was made by the persons administering the ques-
tionnaires to interpret the questions, or influence the
participant’s ideas and responses. After completion, filled
forms were collected and kept under safe custody for entry
and analysis. To minimize contamination, data collection
from DUHS medical college was completed in 2 days and
from AKU medical college over the subsequent two days.
Statistical analysis
Data was entered using Epidata software version 3.1 and
was analyzed using SPSS version 17.0. Simple frequen-
cies were run for individual questions. An independent
t-test was used to compare scores in between groups of
students belonging to different demographic categories
i.e. gender, medical school, year of study, monthly parental
income or parents belonging to medical or pharmaceutical
professions.
Results
Demographics
Out of a total of 353 potential medical students, 303
responded, leading to an overall response rate of 85.8%.
Among these, 102 were males and 201 were females. It
must also be noted that response rate of each question
varied. Representation from the two medical schools was
not uniform; 38.3% (114) of the respondents were from
AKU and the remaining 62.7% (184) belonged to DUHS
Medical College. With reference to the participants’
parents, only 3% had either or both parents working for
pharmaceutical companies, while 27.1% had either or
both parents working as doctors. Tables 1 and 2 depict
the demographics for the respondents in the study.
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Level of acceptability towards interacting and receiving
gifts from pharmaceutical companies
Figure 1 showcases the results with regard to whether or
not students should interact with, and in turn, receive
gifts from pharmaceutical companies. These responses
indicate that 42.7% students believe that there should be
no interaction with drug companies during medical
school. When asked if it was unacceptable for a phys-
ician to receive any gift from a drug company, similar
numbers of students were neutral towards the notion.
Furthermore, when asked whether they themselves would
accept gifts, more than one-third of the students were
comfortable with receiving certain named gifts. Only
30% believed that they would not accept gifts worth any
monetary value (Figure 2). Figures 2a and 2b provide a
contrast between AKU and DUHS students with reference
to the inclination of students from both universities to-
wards such gifts. It is important to note however that
while results show a generally high level of acceptance of
gifts overall, only 19-24% of respondents thought they
would preferentially prescribe a drug that was marketed to
them (Table 3).
One of the most contrasting finding between AKU
and DUHS students was between the level of trust re-
garding information provided by pharmaceutical com-
panies about the drugs. Almost 41% of AKU students
considered information provided by pharmaceutical
companies to be untrustworthy compared to a mere 14%
by DUHS students (p-value <0.05) (Table 3).
Prescription of drugs in return for compensation
Figure 3 shows data on some questions comparing the
two universities sampled. When asked if they would
preferentially prescribe drugs based on benefits they
received from companies, more than 50% students dis-
agreed, from both institutes. However, AKU students
showed a greater degree of mistrust towards drug infor-
mation provided by pharmaceutical companies compared
to DUHS students (p-value <0.05). Furthermore, 78.3% of
AKU students felt that physicians should not be compen-
sated financially each time they prescribe a particular
company’s product, compared to 60.3% students at DUHS
who felt the same way (p-value <0.001).
Pharmaceutical companies and their possible role in
student life
A number of questions addressed the possible role that
drug companies could directly play in student-life; for
example, students were asked if it was acceptable for
drug companies to sponsor events/seminars at medical
colleges. All 9 students whose parent(s) worked for
pharmaceutical companies agreed to accept such spon-
sorships, compared to 81% in the rest of the sample
population. Furthermore, 45.1% students whose parent
(s) were doctors were willing to accept the logo of a
drug company in their lectures, if the company paid for
the cost of lecture notes, compared to 42.1% in the rest
of the sample though the results were not statistically
significant. Additionally, majority of the students were
prepared to accept tuition fee coverage from drug com-
panies in return for attending their seminar. Notably,
around 36% of the respondents from AKU and 26%
from DUHS were comfortable receiving more than 30%
tuition costs from pharmaceutical companies.
Table 1 Demographic distribution of the study
respondents
Demographic feature Quantity (%)
Sex
Male 102 (33.7)
Female 201 (66.3)
Medical college
AKU 114 (38.3)
DUHS 184 (61.7)
Clinical year
3rd 93 (31.2)
4th 132 (44.3)
5th 73 (24.5)
Table 2 Difference in the net monthly parental income of
the two study group respondents
Parents’ income AKUH DUHS
< 50,000 PKR 4 (3.7%) 38 (22.2%)
50,000 - 100,000 PKR 14 (13.0%) 64(37.4%)
100,000 - 150,000 PKR 13 (12.0%) 28 (16.4%)
150,000 - 200,000 PKR 18 (16.7%) 15 (8.8%)
> 200,000 PKR 59 (54.6%) 26 (15.2%)
0% 50% 100%
I would feel
comfortable accepting
gifts
Unacceptable for
physician to receive gift
Students should not
have any interaction
with drug companies in
med school
Disagree
Neutral
Agree
Figure 1 Attitudes of students on the acceptability of gifts
from drug companies.
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Guidelines on interaction with pharmaceutical companies
When enquired about their preformed notions about
pharmaceutical companies, more than 60% students
agreed with the statement that these companies are pri-
marily interested in profit; however they still try to
work in the best interest of doctors and patients. For
both AKU and DUHS, final year medical students
picked this statement more frequently as compared to
3rd or 4th year students.
Additionally, when asked if there was a need to in-
corporate guidelines in the undergraduate curriculum
with regard to interaction with drug companies, 84.2%
students at AKU agreed to it, compared to 54.9% at
DUHS (p-value <0.001). Table 3 showcases these results
broadly.
Attitude score
The attitude score was analyzed by making various sub-
groups of the respondents, though this was not planned
initially. Scores from none of these subgroups appeared
to be significantly different from one another as revealed
(Table 4). One can thus gather from the above findings
that medical student attitudes are more or less similar to
each other regardless of their socio-demographical dif-
ferences. Interestingly, the Attitude scores of AKUH and
DUHS students were also similar.
Discussion
Literature suggests that a physician’s interactions with
pharmaceutical representatives generally begin during
medical school [18]. A vast majority of students are
21.2
6.2
8
12.4
46
6.2 < PKR 25
PKR 25 - 50
PKR 50 - 250
PKR 250 - 500
> PKR 500
NONE
13.1
7.1
14.2
14.218.6
30.1
< PKR 25
PKR 25 - 50
PKR 50 - 250
PKR 250 - 500
> PKR 500
NONE
a b
Figure 2 Acceptability of gifts with monetary value. a. AKU students. b. DUHS students.
Table 3 Comparison between the responses of students from AKUH and DUHS
Question Aga Khan university DUHS Medical college
Disagree (%) Neutral (%) Agree (%) Disagree (%) Neutral (%) Agree (%) P-value1
It is unacceptable for a physician to receive a
gift from a drug company in any form
34.2 40.4 25.4 26.9 44.0 29.1 0.443
I would feel comfortable receiving the following
gifts from a pharmaceutical company: lunch,
palm pilot, penlight, stethoscope, textbook,
watch/jewellery
30.7 28.9 40.4 31.9 31.9 36.3 0.834
I would preferentially prescribe a drug from one
of the companies that provided me with gifts
or incentives
56.1 19.3 24.6 56.5 24.5 19.0 0.429
Students should not have any interaction
with drug companies in medical school
33.6 20.4 46.0 32.1 26.6 41.3 0.457
The information provided about drug effectiveness
from pharmaceutical companies is untrustworthy
15.8 43.9 40.4 41.8 44.0 14.1 <0.05*
It is acceptable for physicians to be compensated
PKR 100 by the drug company each time their
drug is prescribed
78.9 5.3 15.8 60.3 30.4 9.2 <0.001*
It is acceptable for drug companies to sponsor
events/educational seminars during medical school
11.4 8.8 79.8 7.6 9.2 83.2 0.597
If a drug company agreed to pay for the printing
cost of all my class notes in undergraduate medical
school, I would not mind the logo of that company
appearing in the bottom corner of the first slide of
my lectures
34.2 16.7 49.1 44.0 16.8 39.1 0.175
Do you feel that there is a need for incorporating
guidance regarding relationship between the
pharmaceutical industry and the medical professionals
in the undergraduate curriculum
4.4 11.4 84.2 14.1 31.0 54.9 <0.001*
1p-values calculated are for inter-medical college difference *statistically significant.
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exposed to drug-marketing and may become more vul-
nerable to it. Medical students are targeted deliberately
by pharmaceutical companies [4]. Most of these studies
have been conducted in developed countries, whereas
literature from the developing nations remains deficient
(3–5, 20). Student attitudes toward interactions with
pharmaceutical companies reveal the need for further
education and guidance [19]. The results of our study
displayed that students’ understanding about the system
was unclear, at best. A large number of students were
unsure about the appropriateness for doctors and
medical students to receive gifts from pharmaceutical
companies.
Evidence regarding the effect of the length of clinical
training on students’ opinions regarding pharmaceutical
incentives is contradictory. Most studies have concluded
that the level of exposure to pharmaceutical representa-
tives and their incentives differs between clinical and
pre-clinical years, as does the acceptability of these gifts
and offers [5,13,20]. To go a step further, we investigated
the differences in responses among clinical students en-
rolled in three different years of training. Furthermore,
we studied this effect separately for the DUHS Medical
College and AKU in order to get a representation of
the differences in opinions that exist between stu-
dents enrolled in public and private sector institutes,
respectively.
Our study validates the observation that the year of
clinical clerkship indeed has an effect on the student’s
approach towards the pharmaceutical incentives. This
difference within the clinical years was more pro-
nounced for the Aga Khan University: senior medical
students from Year 5 of medical training were more ac-
ceptable of such gifts than students enrolled in clinical
Years 3 and 4. Comparing students from AKUH and
DUHS, we found that final year students from AKU
were more prejudiced in their responses than the final
year students of DUHS. The difference in the private
and public sector was highlighted even further when it
was found that AKU students were more comfortable
with accepting expensive gifts than were DUHS col-
leagues. This may be due to a difference in the level of
exposure of the two groups to pharmaceutical marketing
[5,13]. Secondly, the net monthly parental income dif-
fered significantly between the two groups, which may
directly account for the students’ enrollment in the re-
spective medical colleges (Table 2); it maybe likely that
difference in the socio-economic back ground of the stu-
dents may account for this finding considering that most
students at private university were relatively from a
higher-income family background.
In Pakistan, there is no mechanism to monitor the
drug promotional campaign by pharmaceutical industry:
the extent of physician-industry interactions appears to
affect prescribing and professional behavior of physicians
worldwide as evidenced by most studies conducted in
the developed world [18]. Approximately 90% of the
General Practitioners declare that drug promotion has
definitely had an influence on their prescribing pattern
[21]. In our study, students from private institution, des-
pite being more receptive of expensive gifts offered by
the drug companies, were more skeptical about the in-
formation presented to them by drug companies with al-
most 41% considering the information provided about
drug effectiveness from pharmaceutical companies as
untrustworthy; were less likely to be influenced by these
marketing practices in terms of prescription practices as
noted with low percentage of acceptance of monetary
56.10%
15.80%
78.90%
56.50%
41.80%
60.30%
Preferential
prescription
based on
benefits-
disagree
Information on
drug
effectiveness is
untrustworthy-
disagree
Monetary
compensation
should be given
for prescribing
a drug-
disagree
Aga Khan University Dow Medical College
Figure 3 Comparison of AKU and DUHS attitude on
preferential prescription.
Table 4 Attitude score for demographic variables
Demographic variables Option (n) ATT Score (Mean + Std dev) P-value
Medical college AKUH (110) DUHS (183) 24.3 + 5.9 24.1 + 4.7 0.879
Gender Male (97) Female (196) 24.9 + 5.2 23.8 + 5.1 0.073
Year of study 3rd year (91) 4th year (128) 5th year (69) 23.7 + 5.3 24.8 + 4.8 23.5 + 5.6 0.128
Parent medical doctor Yes (79) No (214) 24.4 + 4.8 24.1 + 5.3 0.731
Parent in the pharmaceutical industry Yes (9) No (284) 25.8 + 2.8 24.1 + 5.3 0.355
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compensation (21% of AKU students) than their public
medical college counterparts (39%), and therefore might
be more aware of the ethical boundaries involving drug
prescription though this needs to be investigated formally.
The better understanding of AKU students might be
attributed to the university hospital policies on doctor-
drug company relationship that exist within AKU.
Looking at the differences pointed out between the two
medical colleges it can thus be suggested that the stu-
dents’ increased acceptability of gifts can possibly stem
from a lack of knowledge of appropriate Medical Student-
Drug Company interaction. Incorporating guidance about
this relationship into their undergraduate curriculum can
be monumental in helping them establish ground rules
and limitations to the acceptable degree of their inter-
action with the drug companies [18,22,23]. Also, limiting
the contact with pharmaceutical representatives might
improve future attitudes and behaviors of these budding
physicians [24].
It is known that attending drug company-sponsored
CME events and accepting funding for travel or lodging
for educational symposia are associated with increased
prescription rates of the sponsor's medication [18]. The
role of pharmaceutical sponsorship in student life is in
fact more controversial. Our study displayed that an
overwhelming majority of students were in favor of
pharmaceutical company sponsored events and educa-
tional seminars. Medical students are in a particularly
interesting position with respect to interactions with
pharmaceutical companies: technically, they are part of
the general population who are free from direct mar-
keting of pharmaceutical products. However, they are
often targeted by marketing from pharmaceutical com-
panies through sponsorship of medical student soci-
eties. Guidelines need to be established dictating the
limitations and drawing out boundaries of the medical
student-pharmaceutical company interaction so as to
facilitate an interaction that suitably benefits both
parties while staying within the ethical domain as de-
scribed by various institutions like AMSA [2].
Interestingly, more AKU students (84%) felt it necessary
to incorporate guidance regarding doctor- pharmaceutical
company interaction in the undergraduate compared to
DUHS Students (54%). These responses further solidify
our claims that AKUH students appear to have a more
definitive understanding and were more critical in their
overall approach towards the issue. The fact that only half
of the students enrolled in the public sector understand
the significance of incorporating guidance for pharmaceut-
ical company interactions with healthcare professionals,
reiterates the need to include such guidance within the
medical curriculum.
To comprehensively assess the relation of various demo-
graphic characteristics of medical student population and
their responses, the Attitude Scoring System was devised.
This is a comprehensive tool which helped us in assessing
the attitude of students towards pharmaceutical compan-
ies and their incentives. The mean Attitude score of the
medical students wandered between 23 and 24 (the ideal-
based on the AMSA guidelines-being a score of 11). Our
study showed no relation of the gender, socio economic
background, parents’ profession as doctors or parents’
employment in a drug company to their attitude towards
pharmaceutical company marketing and incentives. Inter-
estingly, the Attitude scores of AKU and DUHS students
were also similar, despite the individual differences noted
in their pattern of responses. The reason for this was that
AKU students demonstrated a greater acceptability to-
wards gifts and favors as compared to DUHS students.
However, as shown by our results, DUHS students had a
less critical opinion towards the reliability of pharmaceut-
ical information and were more willing to prescribe drugs
based on the benefits offered to them during clinical prac-
tice. This balanced out their mean Attitude score. This
displays a possible limitation of the Attitude scoring sys-
tem: scoring alone is not sufficient in assessing the trends
in thinking—it is simply a tool to assess the overall inclin-
ation of subjects towards pharmaceutical company incen-
tives, though it may differ if this study can be expanded to
more than a few medical colleges and is therefore may be
a question for further study in different demographical
settings.
Limitations
Most of the associations shown by our study have insig-
nificant p-values which may be accounted for by the
small sample size. This resulted because of the overall
small size of the class in the medical college. As this was
the first study in Pakistan addressing this idea to the best
of our knowledge, it provides a good foundation-stone
by showing the high overall inclination of medical stu-
dents towards pharmaceutical incentives and the corre-
sponding need for guidance on the topic since the
actual prevalence of these interactions in general among
Pakistani medical students is unknown. Future studies
with larger samples and participation of multiple medical
schools are needed in order to clearly verify this pheno-
menon and elucidate factors predicting attitudes and
future behaviors of medical students. There was also a lack
of formal assessment of the level of awareness of institu-
tional policies regarding the limitations of pharmaceutical
interactions with physicians, a factor that might have
offered answers to a few of the critical findings. Since this
is a cross-sectional study, we cannot confidently comment
on whether certain factors were temporally related to the
development of particular attitudes in medical students,
however an idea about its prevalence can be made. Pro-
spective or intervention studies are required to clarify such
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concerns. Other factors like awareness of company logic/
business world were also not investigated here.
Generalizability of results is another potential limita-
tion that the investigators identified as the study was
carried out at only two centers in one city of Pakistan and
responses may differ across various cities. Large multi-
center surveys would be help-full to build a complete
picture of the attitudes of medical students across the
country from a wide variety of different backgrounds.
Contamination bias was another potential issue as the
questionnaire was pretested in the same location as our
study sample. In order to minimize contamination we
attempted to complete the data collection as soon as
possible taking a total of 2 days to complete the AKU
sample where the questionnaire was also pretested.
Conclusion and recommendations
The first interaction between the pharmaceutical indus-
try and future health care professionals occurs during
years of medical education. Literature has repeatedly
shown the widespread interaction between medical stu-
dents and pharmaceutical representatives, and a high
level of acceptability towards their gifts and incentives,
giving rise to a concern that whether such an early
exposure will influence prescribing practices of future
physicians and how this issue might be addressed. With
a rapidly evolving pharmaceutical industry in the devel-
oping countries and young doctors joining the field of
medicine there are increased chances of interaction in
the absence of any medical ethics education on the sub-
ject of doctor-pharmaceutical interaction. Our study
findings mirror those from other parts of the world.
Students approached in our study belonging to both
public and private setup had pre-existing opinions re-
garding appropriate doctor-pharmaceutical interaction
and demonstrated a high level of acceptability towards
incentives and gifts offered by them. This acceptability
was not significantly correlated with socio-demographic
variables which we investigated, but a significant differ-
ence existed between the public and private set-up pos-
sibly pointing to the fact that there might be some other
factors in which medical students are trained which have a
substantial impact on their professional ideologies and
ethical standards. Based on some of these finding we can
conclude that it is imperative that every medical college
ideally incorporate guidance regarding doctor pharma-
ceutical interactions, practice clear ethical policies which
medical students should be aware of, and help foster a
supportive environment regarding such social issues so
that our future physicians are more apt to handle them.
Further studies need to be undertaken with a more diverse
student sample and a larger sample size firstly to iden-
tify the prevelance rate of these interactions and sec-
ondly to clearly elucidate reasons that might predict
factors affecting the opinions that students have to-
wards the pharmaceutical industry and help institutions
frame their mode of guidance regarding such issues in a
more feasible way.
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